{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:12:48Z","timestamp":1774991568181,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.urolonc.2022.10.025","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T18:08:10Z","timestamp":1669313290000},"page":"145.e7-145.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0830-7918","authenticated-orcid":false,"given":"Daniel H.","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonna","family":"Shakhnazaryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Shui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian C.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"de Kouchkovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala T.","family":"Borno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpita","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence W.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim S.","family":"Koshkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul R.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix Y.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2022.10.025_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2246","article-title":"Trends in incidence of metastatic prostate cancer in the US","volume":"5","author":"Desai","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.urolonc.2022.10.025_bib0002","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1532-5415.2005.00567.x","article-title":"Quality of life in prostate cancer patients taking androgen deprivation therapy","volume":"54","author":"Dacal","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10.1016\/j.urolonc.2022.10.025_bib0003","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2022.10.025_bib0004","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.10.025_bib0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13014-021-01776-8","article-title":"Radiotherapy of oligometastatic prostate cancer: a systematic review","volume":"16","author":"Rogowski","year":"2021","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.10.025_bib0006","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41391-017-0007-8","article-title":"The use of PET\/CT in prostate cancer","volume":"21","author":"Li","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1016\/j.urolonc.2022.10.025_bib0007","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2022.10.025_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.664225","article-title":"Efficacy of PSMA PET-guided radiotherapy for oligometastatic castrate-resistant prostate cancer","volume":"11","author":"Henkenberens","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2022.10.025_bib0009","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.euo.2020.05.004","article-title":"Metastasis-directed therapy prolongs efficacy of systemic therapy and improves clinical outcomes in oligoprogressive castration-resistant prostate cancer","volume":"4","author":"Deek","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.10.025_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.32509","article-title":"Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: interim outcomes of a prospective clinical trial","volume":"146","author":"Bowden","year":"2020","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.urolonc.2022.10.025_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240892","article-title":"68Ga-PSMA-PET\/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer","volume":"15","author":"Kalinauskaite","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.urolonc.2022.10.025_bib0012","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1200\/JCO.2007.12.4487","article-title":"Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group","volume":"26","author":"Scher","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.urolonc.2022.10.025_bib0013","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s00066-020-01629-5","article-title":"Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy","volume":"196","author":"Henkenberens","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.urolonc.2022.10.025_bib0014","article-title":"Rationale for involved field stereotactic body radiation therapy-enhanced intermittent androgen deprivation therapy in hormone-sensitive nodal oligo-recurrent prostate cancer following prostate stereotactic body radiation therapy","volume":"10","author":"Carrasquilla","year":"2020","journal-title":"Front Oncol"},{"issue":"14","key":"10.1016\/j.urolonc.2022.10.025_bib0015","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJMoa1212299","article-title":"Intermittent versus continuous androgen deprivation in prostate cancer","volume":"368","author":"Hussain","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.urolonc.2022.10.025_bib0016","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.ijrobp.2021.07.873","article-title":"Intermittent androgen deprivation therapy plus comprehensive stereotactic radiotherapy for oligometastatic prostate cancer (CROP)","volume":"111","author":"Cheung","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.urolonc.2022.10.025_bib0017","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clon.2020.03.008","article-title":"Clinical outcomes of stereotactic body radiotherapy with immediate versus delayed hormone therapy in men with oligometastatic recurrence of prostate cancer","volume":"32","author":"Chaw","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"9","key":"10.1016\/j.urolonc.2022.10.025_bib0018","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S1470-2045(19)30415-2","article-title":"18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial","volume":"20","author":"Calais","year":"2019","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2022.10.025_bib0019","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2967\/jnumed.120.251751","article-title":"Disparities in PET imaging for prostate cancer at a tertiary academic medical center","volume":"62","author":"Bucknor","year":"2021","journal-title":"J Nucl Med"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922004252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922004252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T07:50:02Z","timestamp":1741593002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922004252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1078143922004252"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.10.025","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}